HRAS and neoplasm: Of note, case 24 (without CLT) involved a tumor consisting of two sharply demarcated NIFTP components with morphological disparity, that is, high versus low cellularity, while both harbored identical HRAS gene variants, most likely indicating the presence of two morphological components of the same NIFTP lesion.